• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aptose Bioscns (NQ: APTO )

    0.3950 UNCHANGED
    Streaming Delayed Price Updated: 3:47 PM EDT, Oct 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 102
    Open 0.3950
    Bid (Size) 0.3900 (10)
    Ask (Size) 0.4100 (2)
    Prev. Close 0.3950
    Today's Range 0.3950 - 0.3950
    52wk Range 0.3300 - 3.320
    Shares Outstanding 93,653,662
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Aptose Announces Results from Special Meeting of Shareholders
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    -83.40%
    -83.40%
    1 Month
    -3.02%
    -3.02%
    3 Month
    -46.84%
    -46.84%
    6 Month
    -75.00%
    -75.00%
    1 Year
    -85.48%
    -85.48%

    More News

    Read More
    Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday
    Via Benzinga
    Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Recap: Aptose Biosciences Q4 Earnings
    Via Benzinga
    Aptose Announces Adjournment of its Special Meeting of Shareholders
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024
    Via InvestorPlace
    Aptose Reports Results for the Second Quarter 2024
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose Announces Receipt of Deficiency Notice from Nasdaq
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose Biosciences's Earnings: A Preview
    Via Benzinga
    Aptose Announces Results from Annual and Special Meeting of Shareholders
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    APTO Stock Earnings: Aptose Biosciences Beats EPS for Q1 2024
    Via InvestorPlace
    Aptose Reports Results for the First Quarter 2024
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    APTO Stock Earnings: Aptose Biosciences Beats EPS for Q4 2023
    Via InvestorPlace
    Aptose Reports Results for the Fourth Quarter and Full Year 2023
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
    From Aptose Biosciences, Inc.
    Via GlobeNewswire
    Levi Strauss Layoffs 2024: What to Know About the Latest LEVI Job Cuts
    Via InvestorPlace
    Topics Economy Workforce
    Exposures Economy Layoff
    Why Is SU Group (SUGP) Stock Moving Today?
    Via InvestorPlace
    Topics Initial Public Offering
    Exposures Securities Market
    Why Is Aptose Biosciences (APTO) Stock Down Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.